Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$0.85 - $1.4 $65,762 - $108,315
-77,368 Closed
0 $0
Q3 2021

May 17, 2024

BUY
$1.33 - $1.77 $102,899 - $136,941
77,368 New
77,368 $102,000
Q3 2021

Jun 21, 2023

BUY
$1.33 - $1.77 $102,899 - $136,941
77,368 New
77,368 $102,000
Q3 2021

Mar 22, 2023

BUY
$1.33 - $1.77 $64,634 - $86,016
48,597 Added 168.91%
77,368 $102,000
Q3 2021

Nov 15, 2021

BUY
$1.33 - $1.77 $102,899 - $136,941
77,368 New
77,368 $103,000
Q1 2021

May 14, 2021

SELL
$1.61 - $2.77 $46,321 - $79,695
-28,771 Closed
0 $0
Q4 2020

May 24, 2024

SELL
$1.55 - $2.24 $15,937 - $23,031
-10,282 Reduced 26.33%
28,771 $50,000
Q4 2020

Jun 22, 2023

BUY
$1.55 - $2.24 $44,595 - $64,447
28,771 New
28,771 $50,000
Q4 2020

Mar 22, 2023

SELL
$1.55 - $2.24 $15,937 - $23,031
-10,282 Reduced 26.33%
28,771 $50,000
Q4 2020

Feb 16, 2021

SELL
$1.55 - $2.24 $15,937 - $23,031
-10,282 Reduced 26.33%
28,771 $50,000
Q3 2020

May 24, 2024

SELL
$1.91 - $3.08 $81,726 - $131,790
-42,789 Reduced 52.28%
39,053 $76.2 Million
Q3 2020

Jun 26, 2023

BUY
$1.91 - $3.08 $74,591 - $120,283
39,053 New
39,053 $76,000
Q3 2020

Mar 22, 2023

SELL
$1.91 - $3.08 $81,726 - $131,790
-42,789 Reduced 52.28%
39,053 $76,000
Q3 2020

Nov 13, 2020

SELL
$1.91 - $3.08 $81,726 - $131,790
-42,789 Reduced 52.28%
39,053 $76,000
Q2 2020

May 24, 2024

BUY
$1.97 - $3.98 $161,228 - $325,731
81,842 New
81,842 $226 Million
Q2 2020

Jun 26, 2023

BUY
$1.97 - $3.98 $161,228 - $325,731
81,842 New
81,842 $225,000
Q2 2020

Mar 22, 2023

BUY
$1.97 - $3.98 $34,075 - $68,842
17,297 Added 26.8%
81,842 $225,000
Q2 2020

Aug 14, 2020

BUY
$1.97 - $3.98 $34,075 - $68,842
17,297 Added 26.8%
81,842 $226,000
Q1 2020

Jul 12, 2023

BUY
$1.17 - $3.0 $75,517 - $193,635
64,545 New
64,545 $193,000
Q1 2020

Mar 22, 2023

BUY
$1.17 - $3.0 $75,517 - $193,635
64,545 New
64,545 $193,000
Q1 2020

May 15, 2020

BUY
$1.17 - $3.0 $75,517 - $193,635
64,545 New
64,545 $194,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.